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Introduction. Lyme disease, the most common vector-borne illness, is usually caused by 
infection with the spirochete Borrelia burgdorferi. Worldwide, higher prevalence is noted 
in Central, Eastern, and Northern Europe, the US and Canada, and parts of Asia. The dis-
ease is transmitted to humans via tick bites. The typical symptoms include fever, head-
ache, fatigue, sore muscles and joints, and a characteristic skin rash called erythema mi-
grans. Currently, the majority of the international guidelines recommend the testing of 
blood for evidence of antibodies against the Lyme disease bacteria using the blood sample 
and fluid from the central nervous system. The basic Lyme test is called an enzyme-linked 
immunosorbent assay (ELISA). Therefore, every positive or uncertain Lyme ELISA result 
needs to be confirmed with Western blot test. Reducing exposure to ticks is the best de-
fense against Lyme disease and other tick-borne infections.  
Material and methods. The objective of the study was to carry out an analysis of the 
literature related laboratory diagnosis of Lyme disease and was based on 79 bibliographic 
sources of authors across the country and abroad using Academic Google and PubMed 
databases for articles published from 2012-2021. 
Results. This review details the risk factors, clinical presentation, diagnoses treatment, 
and prophylaxis for the disease. The prime season for tick-borne disease begins when 
weather becomes warmer, people enjoy outdoor activities in woody or brushy areas and 
the ticks begin to be more active. People in certain occupations, for example, farm work-
ers, are at higher risk. Typically, the tick must feed for at least 36 hours for transmission 
of the causative bacterium, Borrelia burgdorferi. 
The diagnosis of Lyme disease is based on symptoms, physical findings, the possibility of 
being exposed to areas where infected ticks could be present and laboratory testing.  
In recent years the issue of the diagnosis of this infection has been highly publicized. La-
boratory tests check for antibodies in the blood however Lyme disease antibodies may 
first appear six to eight weeks after a person has been bitten by a tick. A good occupa-
tional, travel, and lifestyle history is important when assessing patients. Early laboratory 
tests may not detect the disease and could slow diagnosis.  The disease is associated with 
specific clinical features: early localized infection, with erythema migrans, fever, malaise, 
fatigue, headache, myalgias, and arthralgias; early disseminated infection, with neuro-
logic, musculoskeletal, or cardiovascular symptoms, multiple erythema migrans lesions 
and late neurologic manifestations may occur.  
Lyme disease is most commonly diagnosed by a screening test called ELISA, then con-
firmed using a western blot test, but in some cases also by testing a sample of the skin 
lesion by nucleic acid testing or culture. Some laboratories can analyze the tick to see if 
it's carrying Lyme bacteria. Lyme disease prevention measures described in the majority 
of the analyzed studies are the following: use insect repellent, remove ticks immediately 
with fine-tipped tweezers, apply pesticides to lawns and other high-risk areas, properly 
maintain yard or land, walk in the center of hiking trails and wear light-colored clothing 
to make it easier to find ticks on your body. 
Conclusions. Prompt diagnosis and early treatment are extremely critical for Lyme dis-
ease because it helps reduce the risk the development of further symptoms. Preventive 
measures should be emphasized to patients to help reduce risk.  
 
